Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Intangibles (2023 - 2025)

Perspective Therapeutics (CATX) has disclosed Intangibles for 7 consecutive years, with $40.0 million as the latest value for Q4 2025.

  • Quarterly Intangibles fell 20.0% to $40.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40.0 million through Dec 2025, down 20.0% year-over-year, with the annual reading at $40.0 million for FY2025, 20.0% down from the prior year.
  • Intangibles hit $40.0 million in Q4 2025 for Perspective Therapeutics, down from $50.0 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $50.0 million in Q1 2023 to a low of $40.0 million in Q4 2025.
  • Historically, Intangibles has averaged $49.2 million across 3 years, with a median of $50.0 million in 2023.
  • Biggest five-year swings in Intangibles: changed 0.0% in 2024 and later dropped 20.0% in 2025.
  • Year by year, Intangibles stood at $50.0 million in 2023, then changed by 0.0% to $50.0 million in 2024, then fell by 20.0% to $40.0 million in 2025.
  • Business Quant data shows Intangibles for CATX at $40.0 million in Q4 2025, $50.0 million in Q3 2025, and $50.0 million in Q2 2025.